Tag: Biotech and Pharmaceuticals
FDA cancels vaccine advisory meeting for choosing flu strains for next...
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. Jason Reed |...
Eli Lilly plans at least $27 billion in new U.S. manufacturing...
Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand...
Shortage of Novo Nordisk’s Wegovy and Ozempic drugs is resolved, FDA...
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Hollie Adams | ReutersThe long-running U.S. shortage of Novo Nordisk's...
UnitedHealth’s rough stretch continues, with buyouts, a reported DOJ probe and...
FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California April 13, 2016. Mike...
From pills to new uses, here’s what Eli Lilly’s top scientist...
Dan Skovronsky knows what makes a good obesity drug.As chief scientific officer at Eli Lilly, he's already done it once with the company's...
UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue...
A general view outside the United Healthcare corporate headquarters on December 4, 2024 in Minnetonka, Minnesota. Stephen Maturen | Getty ImagesUnitedHealthcare is offering certain...
Moderna beats on revenue but loses more than expected as it...
Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to...
CVS shares are up 45% this year — here’s why it...
The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada, on Feb. 7, 2024.Patrick...
CVS shares pop 15% on big earnings beat, even as high...
CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical...
CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic’ practices
David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10,...
